Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

By R. Dworkin, Alec B. O’Connor, J. Audette, R. Baron, G. Gourlay, M. Haanpää, Joel L. Kent, E. Krane, Alyssa A. Lebel, R. Levy and 12 more. Mayo Clinic proceedings, 2010

1,271 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Physiology, Surgery

View Paper: https://www.semanticscholar.org/paper/9baaad5983a0e65916612b003c268362c9c4db7f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Anesthesiology and Pain Medicine

1. Clifford J. Woolf
2. N. Finnerup
3. T. S. Jensen
4. Lee Simon
5. S. Sindrup

In Physiology

1. Clifford J. Woolf
2. N. Finnerup
3. T. S. Jensen
4. Lee Simon
5. S. Sindrup
6. Arne May
7. R. Ji
8. R. Baron

In Surgery

1. Clifford J. Woolf
2. Lee Simon

Citations in the corpus

• The evidence for pharmacological treatment of neuropathic pain (2010, background): “In addition comparative randomized double-blind trials of first-line drugs (tricyclic antidepressants (TCAs), serotonin noradrenaline reuptake inhibitors (SNRIs), topical lidocaine, gabapentin, and pregabalin [5,25] for neuropathic pain conditions were included.”
• RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH (2012, background): “Most often these adjuvant medications are in the anticonvulsant (Dworkin et al., 2010) or psychotropic classes (Attal et al.”
• Central sensitization: Implications for the diagnosis and treatment of pain (2010, background): “ments for neuropathic pain [72], reinforces the importance of the central component of the pain and its suitability as a target for”